Oncomine Dx Target Test

FDA Premarket Approval P160045 S038

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DeviceOncomine Dx Target Test
Generic NameNext Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
ApplicantLIFE TECHNOLOGIES CORPORATION5781 Van Allen Waycarlsbad, CA 92008 PMA NumberP160045 Supplement NumberS038 Date Received08/05/2022 Decision Date02/01/2023 Product Code PQP  Advisory Committee Pathology Clinical TrialsNCT02609776 Supplement Typenormal 180 Day Track No User Fee Supplement Reason Labeling Change - Pas Expedited Review Granted? No
Date Received2022-08-05
Decision Date2023-02-01
PMAP160045
SupplementS038
Product CodePQP 
Advisory CommitteePathology
Supplement TypeNormal 180 Day Track No User Fee
Supplement ReasonLabeling Change - Pas
Expedited ReviewNo
Combination ProductNo
Applicant AddressLIFE TECHNOLOGIES CORPORATION
5781 Van Allen Way
carlsbad, CA 92008 PMA NumberP160045 Supplement NumberS038 Date Received08/05/2022 Decision Date02/01/2023 Product Code PQP  Advisory Committee Pathology Clinical TrialsNCT02609776
Supplement Typenormal 180 Day Track No User Fee Supplement Reason Labeling Change - Pas Expedited Review Granted? No Combination ProductNo Approval Order Statement  
Approval To Update The User Guide For The Oncomine Dx Target Test To Include The Results Of The Supplemental Clinical Data Submitted In The Post-Approval Study (PAS) Report P160045/R015

Supplemental Filings

Supplement NumberDateSupplement Type
P160045Original Filing
S038 2022-08-05 Normal 180 Day Track No User Fee
S037 2022-06-14 Real-time Process
S036 2022-03-29 135 Review Track For 30-day Notice
S035 2022-03-08 Panel Track
S034 2021-12-23 Normal 180 Day Track No User Fee
S033
S032
S031
S030 2021-05-14 30-day Notice
S029
S028
S027
S026
S025
S024 2020-11-06 30-day Notice
S023 2020-10-01 30-day Notice
S022 2020-09-11 30-day Notice
S021
S020 2020-05-14 30-day Notice
S019
S018 2019-10-16 30-day Notice
S017
S016 2019-07-22 30-day Notice
S015 2019-04-23 30-day Notice
S014 2019-01-31 30-day Notice
S013 2019-01-25 30-day Notice
S012 2018-11-13 30-day Notice
S011 2018-10-19 30-day Notice
S010 2018-10-09 30-day Notice
S009
S008 2018-07-20 30-day Notice
S007
S006 2018-05-02 30-day Notice
S005 2018-03-22 Normal 180 Day Track No User Fee
S004
S003 2017-11-20 30-day Notice
S002 2017-11-08 30-day Notice
S001 2017-07-28 30-day Notice

NIH GUDID Devices

Device IDPMASupp
10190302015103 P160045 000
10190302006156 P160045 000
10190302006095 P160045 000
10190302006064 P160045 000
10190302015646 P160045 000
10190302006071 P160045 000
10190302017756 P160045 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.